Variant report
Variant | esv3327154 |
---|---|
Chromosome Location | chr3:86565462-86568660 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:86558263..86561216-chr3:86563016..86565954,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575830356 | chr3:86567963-86567964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192361703 | chr3:86568010-86568011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536170749 | chr3:86568015-86568016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183286910 | chr3:86568035-86568036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544917969 | chr3:86568051-86568052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572660562 | chr3:86568052-86568053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533739682 | chr3:86568090-86568091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558341013 | chr3:86568107-86568108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371360939 | chr3:86568135-86568136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186897704 | chr3:86568139-86568140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141055886 | chr3:86568163-86568164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562529207 | chr3:86568174-86568175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11925417 | chr3:86568184-86568185 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs113413677 | chr3:86568202-86568203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9863183 | chr3:86568229-86568230 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs36095487 | chr3:86568240-86568241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540435481 | chr3:86568325-86568326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560778464 | chr3:86568387-86568388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114786526 | chr3:86568410-86568411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552761534 | chr3:86568435-86568436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564393284 | chr3:86568440-86568441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531867627 | chr3:86568504-86568505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113516969 | chr3:86568508-86568509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144904348 | chr3:86568528-86568529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536133850 | chr3:86568535-86568536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs548032359 | chr3:86568558-86568559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566449786 | chr3:86568571-86568572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533712992 | chr3:86568574-86568575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74563978 | chr3:86568603-86568604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576839579 | chr3:86568607-86568608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140546395 | chr3:86568631-86568632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555874121 | chr3:86568639-86568640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs574442855 | chr3:86568660-86568661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:86567800-86568600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:86568600-86569800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |